Impax completes acquisitions Of Tower Holdings and Lineage Therapeutics
MLex Summary: Technology-based specialty pharmaceutical company Impax Laboratories said Tuesday that the company has successfully completed its planned acquisitions of Lineage Therapeutics and Tower Holdings, including subsidiaries CorePharma and Amedra Pharmaceuticals.Statement follows in full....To view the full article, register now.
Already a subscriber? Click here to view full article